We examined whether PRA2 complements any of the yeast ypt mutants and found again that PRA2 does not complement but rather confers the growth defect to some of the ypt mutants. No growth defect was observed when PRA2 was expressed in the wild-type yeast cells. Unlike the case of Ara4, neither Arabidopsis nor yeast GDI remedied the growth defect by Pra2, indicating that the mechanism of the exacerbation is different. Mutational analysis of PRA2 suggests that the growth inhibition can be ascribed to unidentified factor(s) which prefers the GTP-bound form of Pra2. This yeast system will be useful for identifying such putative regulatory factor(s) from yeast and plants and analyzing their interactions with Pra2.
Small GTPases of the Rab/Ypt family function in targeting and/or fusion of transport vesicles to the acceptor membrane in the exocytic and endocytic pathways. Extensive genetic and biochemical studies have elucidated the roles of Rab/Ypt proteins and their regulators in yeast and mammalian cells (for reviews, see Novick and Zerial, 1997; Lazar et al., 1997; Martinez and Goud, 1998) . A large number of Rab/Ypt family GTPases have also been identified from higher plants (for reviews, see Ma, 1994; Uchimiya et al., 1998) . Some plant RAB/YPT genes complement yeast Saccharomyces cerevisiae ypt mutants indicating evolutionary conservation of this family (Cheon et al., 1993; Bednarek et al., 1994; Park et al., 1994; Fabry et al., 1995; Loraine et al., 1996; Kim et al., 1996) . However, we found that the expression of the Arabidopsis Rab protein, Ara4 (Anai et al., 1991) , aggravates the growth defect of a series of yeast ypt mutants (Ueda et al. 1996) . We postulated that this phenomenon was due to the titration of common regulator(s) of yeast Ypt proteins by Ara4 and proved it by the isolation of Arabidopsis cDNA clones that suppress the Ara4-induced growth defect in ypt1 mutant cells (Ueda et al., 1996) . One such clone was AtGDI1, the first identified regulator of Rab/Ypt proteins in higher plants. This approach has enabled us to use the yeast system not only for identifying plant regulators of plant Rab proteins but also for examining the mode of interactions between plant proteins.
PRA2 is a pea Pisum sativum gene encoding a Rab GTPase (Pra2), whose expression is repressed by light Yoshida et al., 1993) . Interestingly, Pra2 is localized only in the growing region of the etiolated seedling, suggesting that Pra2 functions in stem elongation during skotomorphogenesis (Nagano et al., 1995) . Pra2 shows best similarity to Ypt31/Ypt32 among the Ypt proteins of yeast S. cerevisiae. Ypt31/Ypt32 function around the Golgi compartment (Benli et al., 1996; Jedd et al., 1997) . Pra2 and Ypt31/Ypt32 are 47% identical and the sequence of the effector region, a structural landmark for functional specificity, is completely the same.
We examined whether PRA2 can complement any of yeast ypt mutants. PRA2 complemented none of them but again inhibited the growth of several ypt mutants as is the case of ARA4. However, the mechanisms of the exacerbation turned out to be different between these two plant Rab proteins.
Materials and Methods

Yeast strains and culture conditions
The Saccharomyces cerevisiae strains used in this study are listed in Table I . Yeast cells were grown in YP medium [2% (w/v) polypeptone (Nihon Pharmaceutical Co. Ltd., Tokyo, Japan) and 1% (w/v) yeast extract (Difco Laboratories, Inc., Detroit, MI, USA)] containing 2% (w/v) glucose (YPD) or in MC medium [0.67% (w/v) yeast nitrogen base without amino acids (Difco Laboratories) and 0.5% (w/v) casamino acids (Difco Laboratories)] containing 2% (w/v) glucose (MCD) supplemented appropriately. For derepression of the GAL1 promoter, MC medium was supplemented with 5% galactose and 0.2% sucrose (MCGS). Yeast transformation was performed by a lithium thiocyanate method (Keszenman-Pereyra and Hieda, 1988) .
Plasmids
Plasmids and oligonucleotides used in this study are listed in Table  II . Underline indicates mutated or inserted nucleotides. The singlecopy plasmid pYO773 harboring the GAL1 promoter and the URA3 marker was provided by H. Qadota of the Nara Institute of Science and Technology. The multicopy plasmid containing the genomic clone of MSI4, pKT188, was provided by A. Toh-e of the University of Tokyo. The single-copy plasmid pNMV3 harboring the GAL1 promoter and the HIS3 marker was constructed by subcloning the BamHI-SalI fragment of pYO773 into pRS313 (Sikorski and Hieter, 1989) . The single-copy plasmid pNMV4 harboring the GAL1 promoter and the TRP1 marker was similarly constructed from pYO773 and pRS314 (Sikorski and Hieter, 1989) .
Expression of wild-type and mutant PRA2 in yeast cells
For the overproduction of Pra2 in yeast cells, PRA2 was subcloned into the EcoRI site behind the GAL1 promoter of pYO773. The constructed plasmid was named pGPR3. Mutant alleles of PRA2 were made by PCR-mutagenesis with the primers NM21 and NM22 for PRA2T34N, NM23 and NM24 for PRA2T52A, NM25 and NM26 for PRA2Q79L, NM27 and NM28 for PRA2N133I, and NM29 and NM19 for PRA2∆C. These alleles were also subcloned into the EcoRI site of pYO773. The resulting plasmids were designated pGPR334, 352, 379, 3133, and 3C for PRA2T34N, T52A, Q79L, N133I, and ∆C, respectively.
Coexpression of GDI, GFC, and REP with PRA2
The plasmid harboring the GAL1-promoter-driven PRA2 and the HIS3 marker was constructed by inserting PRA2 into the EcoRI site of pNMV3 and named pGPR4. pGPR5 harboring the GAL1-promoter-driven PRA2 and the TRP1 marker was similarly constructed from pNMV4. pGPR4 and pGPR5 conferred a growth defect to ypt1 and ypt31ts as well as pGPR3 (not shown). GDI1/ SEC19 was isolated from the yeast genome by PCR using the primers NM7 and NM10. The PCR product was sequenced and inserted into the BglII site behind the GAL1 promoter of pYO773. The resulting plasmid was named pNMY191. DSS4 was isolated from the yeast genome by PCR using the primers NM5 and NM6. The PCR product was sequenced and inserted into the BglII site of pYO773. The constructed plasmid was designated pDSS41. Plasmid harboring both PRA2 and GDI1/SEC19 was constructed by inserting the BamHI-SalI fragment of pGPR3 into pYES2 (Invitrogen, Leek, The Netherlands). The XhoI-SalI fragment of the resulting plasmid were inserted into the XhoI site of pNMY191 to yield pGGR3D, harboring both GAL1-promoter-driven PRA2 and GAL1-promoter-driven GDI1/SEC19. ypt1 mutant cells carrying pGPR4 were transformed with pNMY191, pDSS41, or pKT188 for coexpression of GDI1/ SEC19, DSS4 or MSI4, respectively. ypt31ts cells carrying pGPR5 Yoo et al., 1999; d, Nakano and Muramatsu, 1989; e, Nakano et al., 1988 were transformed with pNMY191 or pDSS41 for coexpression of GDI1/SEC19 or DSS4, respectively. pGGR3D was used for the coexpression of GDI1/SEC19 in the ypt31cs and sec19 mutants.
Immunoblotting of Pra2
Yeast cells carrying PRA2 were cultured in the MCD liquid medium to an early log phase, harvested and resuspended in the MCGS medium for the derepression of the GAL1 promoter. Cells were incubated for 4 h for ypt1, ypt31cs, and sec19, and for 72 h for ypt31ts, because it took a long time (>50 h) to induce the GAL1 promoter in ypt31ts (not shown). They were harvested again, washed with 10 mM NaN3, and resuspended in 200 µl of SDS buffer (2% SDS and 10% glycerol in 50 mM Tris-HC, pH 6.8).
Glass beads (0.2 g) were added to the cell suspension and the cells were lysed by repeated vigorous vortexing and chilling on ice. Extracts were boiled for 5 min and centrifuged to collect supernatant. The cleared yeast cell lysates were subjected to immunoblotting with a monoclonal anti-Pra2 antibody (Nagano et al., 1995) at 1:5,000 dilution. SDS-PAGE and immunoblotting were performed by conventional methods (Maniatis et al., 1982) .
Results
PRA2 aggravates the growth defect of a series of yeast ypt mutants
We first examined whether PRA2 can complement yeast ypt mutants. PRA2 was placed under control of the GAL1 promoter on a single-copy plasmid and introduced into 
yeast mutant strains as shown in Table I . These strains harbor temperature-sentive (ts) or cold-sensitive (cs) mutations in YPT1, YPT31/YPT32, and SEC4, all encoding Rab/Ypt-family small GTPases. Ypt1, Ypt31/Ypt32, and Sec4 function in ER-to-Golgi, around the Golgi, and Golgito-plasma-membrane transport, respectively (Lazar et al., 1997) . PRA2 complemented none of them. However, we realized that PRA2 conferred a growth defect to ypt1 (TSU3-5D), ypt31cs (YTH12), and ypt31ts (YLX8) mutants even at their permissive temperature (Table III ; Fig. 1 ). In other words, the combination of the ypt1 or ypt31 mutation with the overexpression of PRA2 leads to synthetic growth defects. The effect was striking with the ypt1 mutant, whose growth was almost completely ceased by the expression of PRA2. No growth defect was observed in the wild-type strain, ANY21 (Fig. 1) , or the isogenic control strain of ypt31cs, YTH11 (not shown). Growth of ypt32 and sec4 was essentially unaffected. These results imply that Pra2 titrates common regulator(s) of Ypt proteins in yeast cells and consequently exacerbates the growth defect of various mutants, as is the case of Ara4 in yeast (Ueda et al., 1996) .
PRA2 aggravates the growth defect of yeast sec19 mutant
The coexpression of Arabidopsis GDP dissociation inhibitor (GDI), AtGDI1/AtGDI2, overcomes the deleterious effect of ARA4 expression in the ypt1 mutant, indicating that the titration of GDI by Ara4 is the major cause of the growth defect (Ueda et al., 1996; . Because GDI potentially interacts with all Rab/Ypt-family GTPases (Ullrich et al., 1993) , the yeast GDI may well interact with Pra2. In yeast S. cerevisiae, GDI1/SEC19 is the only gene encoding GDI, which is believed to function for all yeast Ypt proteins (Garrett et al., 1994) . As shown in Figure 2 , the growth of the sec19 mutant was inhibited by the expression of PRA2 even at the permissive temperature of 30°C. This supported the idea that GDI was being titrated by Pra2 as was the case with Ara4.
Coexpression of GDI1 did not remedy the growth defect in ypt mutants
To verify this hypothesis directly, we examined whether the coexpression of yeast GDI can suppress the growth defect induced by Pra2. GDI1/SEC19 was placed behind the GAL1 promoter on a single-copy plasmid and expressed simultaneously with PRA2 in sec19, ypt1, ypt31ts, and ypt31cs mutants. The coexpression of GDI1/SEC19 could complement not only the temperature-sensitivity of the sec19 mutant, but also the growth defect of sec19 caused by PRA2 (Fig. 3A) . Immunoblotting with the anti-Pra2 antibody confirmed that Pra2 was expressed under this condition (Fig. 3B ). This result is reasonable because the GAL1-promoter-driven GDI1/SEC19 complements the sec19 mutation. In contrast, the coexpression of GDI1/ SEC19 with PRA2 in ypt1, ypt31cs, and ypt31ts mutants did not remedy the growth defect at all (Table IV) . We also examined the effect of Arabidopsis GDI, AtGDI1 (Ueda et al., 1996) or AtGDI2 . Neither of them could suppress the growth defect caused by Pra2 in the ypt1 mutant (data not shown). These results indicate that the growth inhibition in ypt mutants by Pra2 is not ascribable to the titration of GDI, unlike the case of Ara4. (Seabra et al., 1992; Ullrich et al., 1993; Burton et al., 1994; Nuoffer et al., 1997; Collins et al., 1997) . As described above, however, the coexpression of GDI did not remedy the growth defect of either ypt1 or ypt31 (Table IV) . Then, could GFC or REP be the titrated factor? In yeast cells, Dss4 and Msi4 are considered to function as GFC and REP, respectively (Fujimura et al., 1994; Collins et al., 1997) . We examined whether the multicopy MSI4 or the GAL1-promoter-driven DSS4 on a single-copy plasmid can rescue the growth defect caused by PRA2 in the ypt1 mutant. As shown in Table V , neither DSS4 nor MSI4 recovered the growth defect caused by PRA2, implying that these gene products are not the limiting factor in the ypt1 mutant overexpressing Pra2.
Other possible regulators, DSS4 and MSI4, did not rescue the growth defect
Unknown factor(s) which prefers the GTP-bound form of Pra2 is causing the growth defect of ypt1 and ypt31ts
To obtain a clue to identify the factor that is titrated by Pra2, we performed a mutational analysis of PRA2. First, a PRA2 variant without the C-terminal CXC motif (PRA2∆C) was constructed and examined as to whether it confers the growth defect to ypt mutants. Double geranylgeranyl groups are added on this C-terminal CXC motif of Rab/Ypt proteins Fig. 1 . PRA2 conferred growth defect to yeast ypt mutants. Cells of ypt1 (TSU3-5D), ypt31cs (YTH12), ypt31ts (YLX8), and wild-type (ANY21) carrying either GAL1-promoter-driven PRA2 (pGPR3) or vector alone (pYO773) were streaked on MCD and MCGS media and were incubated at 23°C for 4 to 7 days. and this modification is required for their membrane localization and interaction with GDI. Interestingly, PRA2∆C does not inhibit the growth of sec19 and ypt31cs mutants, but inhibits that of the ypt1 and ypt31ts mutants as well as the wild type PRA2 (Fig. 4A) . Immunoblotting with the anti-Pra2 antibody confirmed that the mutant Pra2 (Pra2∆C) was stable as the wild-type Pra2 in sec19, ypt31cs (Fig. 4B) , ypt31ts, and ypt1 mutants (not shown). This result indicates that Pra2 titrates multiple factors and the factor causing the growth defect of sec19 and ypt31cs should be different from that of ypt1 and ypt31ts. It also suggests that the factor affecting the growth defect of sec19 and ypt31cs interacts with the C-terminal CXC motif of Pra2. For further characterization of the mode of interactions, four novel mutant alleles of PRA2 (PRA2T34N, T52A, Q79L, and N133I) were constructed and expressed under control of the GAL1 promoter on a single-copy plasmid. Description of each allele is summarized in Table VI . Like wild-type PRA2, these mutant alleles of PRA2 did not confer any growth defect to wild-type yeast cells (not shown). Interestingly, the growth defect of ypt1 and ypt31ts was almost completely lost when the T34N mutation, which is equivalent to S17N of Ras and is believed to fix the protein in the GDP-form, and the N133I mutation, which stabilizes the nucleotide-free form, were introduced (Fig.  5A) . On the contrary, neither the T52A mutation in the effector domain nor the Q79L mutation, which fixes Pra2 in the GTP-form, restored the growth inhibition in ypt1 and ypt31ts mutant at all. Immunoblotting with the anti-Pra2 antibody showed that the T34N and N133I mutant proteins were stable, although their levels were a little lower than others in the ypt1 mutant (Fig. 5B) . All mutant alleles of PRA2 affected the growth of ypt1 and ypt31ts in a similar fashion. These results suggest that the growth inhibition of ypt1 and ypt31ts could be ascribed to common unidentified factor(s) which can interact with the GTP-bound form of Pra2 but not with the GDP-or nucleotide-free form of Pra2.
Discussion
PRA2 causes growth defect of yeast ypt mutants
Among the large family of Rab/Ypt GTPases, plant members contain unique ones, pea Pra2 and Pra3, whose (pYO773), PRA2 (pGPR3), or both PRA2 and GDI1/SEC19 (pGGR3D). Cells were streaked on MCGS plate and incubated for 3 days at 30°C and for 8 days at 37°C. Coexpression of GDI1/SEC19 complemented the temperature sensitivity (right panel) and remedied the growth defect caused by PRA2 in sec19 mutant (left panel). (B) Pra2 was not degraded by coexpression of GDI1/SEC19. Cells of sec19 mutant carrying the indicated plasmids were cultured in MCGS medium for 4 h at 30°C and were subjected to immunoblotting using anti-Pra2 antibody. Fifty µg protein was loaded per lane. Fig. 4 . PRA2∆C does not inhibit the growth of sec19 and ypt31cs, but inhibits the growth of ypt1 and ypt31ts. (A) Cells of sec19, ypt1, ypt31cs, and ypt31ts were transformed with GAL1-promoter-driven PRA2 (pGPR3), PRA2∆C (pGPR3C), or vector alone (pYO773) and incubated on MCD and MCGS media. Each transformant was incubated at the indicated temperature for 4 days for sec19 and ypt1, 5 days for ypt31cs, and 8 days for ypt31ts, respectively. (B) immunoblotting with anti-Pra2 antibody. Cells of ypt31cs and sec19 were cultured at 23°C and 30°C, respectively, in MCGS medium for 4 h and were subjected to immunoblotting. Fifty µg protein was loaded per lane. expression is regulated by light (Yoshida et al., 1993) . To better understand their function, we decided to examine the relationship between Pra2 and well-characterized yeast Ypt proteins. In our attempt of yeast complementation, we found that the expression of PRA2 did not complement any of the yeast ypt mutants we examined but rather aggravated the growth of ypt1 and ypt31 even at the permissive temperature. This observation was quite similar to what we found before with the Arabidopsis Rab protein Ara4 (Ueda et al., 1996) . In the case of Ara4, we showed that yeast factors interacting with Ypt proteins were titrated by the heterologous Ara4 expression, and that this was the major cause of the growth inhibition phenotype. In fact, by the screening of plant cDNA clones that suppress this growth defect, we identified AtGDI1, an Arabidopsis counterpart of Rab GDI, as the first regulator of higher plant small GTPase (Ueda et al., 1996) . However, the present study reveals that the mechanisms of growth aggravation are different between Ara4 and Pra2.
Mode of interaction between Pra2 and the titrated factors
In contrast to the case of ARA4, neither Arabidopsis GDI (AtGDI1 and AtGDI2) nor yeast GDI (GDI1/SEC19) overcomes the growth defect caused by PRA2, indicating that GDI is not the limiting factor in this case. We performed a mutational analysis of PRA2 to obtain a clue to the causal factor. Many mutants of small GTPase have been biochemically characterized mostly through the studies of Ras, and much knowledge has accumulated (for reviews, see Polakis and McCormick, 1993; Feig, 1999) . We constructed five mutant alleles of PRA2, PRA2T34N, T52A, Q79L, N133I, and ∆C, and examined whether they confer the growth defect. Interestingly, the GDP-form T34N mutation and the nucleotide-free-form N133I mutation abolished the growth defect almost completely. In contrast, the GTP-form Q79L mutation did not affect the growth inhibition. These results suggest that the factor being titrated by Pra2 prefers the GTP-bound form.
Our current model is illustrated in Figure 6 . Factor X interacts tightly with the GTP-bound form of Pra2 and its titration inhibits the growth of ypt1 and ypt31ts mutants. Factor Y requires the geranylgeranyl group for the interaction with Pra2 and its decrease inhibits the growth of sec19 and ypt31cs mutants. Pra2∆C, which lacks the Cterminal geranylgeranylation site, cannot interact with and titrate Factor Y and thus does not confer the growth defect to sec19 or ypt31cs. Pra2T34N and Pra2N133I, GDP-form and nucleotide-free-form mutants, cannot titrate Factor X and thus do not cause the growth defect of ypt1 and ypt31ts. Then, what are Factors X and Y? Several known regulators of Rab/Ypt, GDI (Gdi1/Sec19), GFC (Dss4), and REP (Msi4), were considered as candidates, but coexpression experiments showed that none of them fits these roles. Genetic interaction between YPT1 and YPT31 implies that they share common regulators (Yoo et al., 1999) . Recently, Yang et al. (1998) identified Yip1 as a protein that interacts with both Ypt1 and Ypt31. However, as Yip1 does not interact with the GTP-form mutant of Ypt1 or Ypt31 (Yang et al., 1998) , Yip1 is not likely to be Factor X. To identify the factor(s) titrated by Pra2, we attempted to screen for plant cDNAs whose expression can suppress the growth defect by PRA2 in the ypt1 mutant (Matsuda and Nakano, unpublished). However, in our screening of 10 5 Arabidopsis cDNA clones, no clear suppressor clone was obtained. Perhaps the screening is not saturated yet and further trials will hopefully help identify the causal factor(s).
The yeast expression system gives further opportunities to study plant Rab proteins
To summarize, the growth inhibition phenotype of PRA2 expression in yeast ypt mutants, which first looked similar to that of ARA4, turns out to be quite different in terms of titrated components. This indicates that the yeast expression system provides a vast possibility of identifying regulators and analyzing their interactions with Rab/Ypt proteins. The physiological nature of this system would be useful especially for plant genes, for which convenient ways of functional analysis remain to be developed. 
